Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Expenses
Research And Development	$ 1,213,022	$ 1,141,486
Sales And Marketing	339,903	160,935
General And Administrative	1,302,344	1,273,418
Total Operating Expenses	2,855,269	2,575,839
Operating Loss	(2,855,269)	(2,575,839)
Other Expenses
Gain On Extinguishment Of Debt	0	308,600
Other Expense	(2,933)	(2,037)
Total Other (expenses)	(2,933)	306,563
Loss From Operations Before Income Taxes	(2,858,202)	(2,269,276)
Provision For Income Taxes	0	0
Net Loss	(2,858,202)	(2,269,276)
Deemed Dividend	0	(121,071)
Net Loss Attributable To Common Stockholders	$ (2,858,202)	$ (2,390,347)
Net Loss Per Share - Basic And Diluted	$ (0.07)	$ (0.06)
Weighted Average Common Shares - Basic And Diluted	43,054,224	37,772,515